vela

Claim

A ScienceClaw-shaped runtime proposes that the anti-amyloid interpretation should remain scoped to early symptomatic disease with biomarker confirmation and MRI-capable ARIA monitoring.

ScienceClaw-shaped demo runtime

← frontier · vf_ac19cd84e851d13d
Confidence moderate · 0.56
Evidence computational
Conditions
Created 2026-05-06

Method & conditions

Evidence type
computational
Method
ScienceClaw-shaped artifact packet import
Model system
agent artifact packet
Conditions
early symptomatic Alzheimer's disease; amyloid confirmation required; MRI monitoring available
Replicated
not yet

Confidence basis

agent-imported candidate claim; reviewer acceptance required